• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ALINITY CI-SERIES SYSTEM CONTROL MODULE; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ALINITY CI-SERIES SYSTEM CONTROL MODULE; ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE Back to Search Results
Catalog Number 03R70-01
Medical Device Problem Code Computer Software Problem (1112)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/30/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The alinity ci-series scm module, serial number (b)(6) system software v3.6.0 was configured to override reagent lot expiration.Samples were run on the expired reagent, but no flags were generated when controls and patient samples ran on the expired reagent.A review of tracking and trending data did not identify a trend associated with the issue described in this complaint.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of the alinity ci-series system control module (scm), serial number (b)(6) and alinity system software was identified.
 
Event or Problem Description
The customer observed an expired lot of glucose reagent which was not removed by the alinity ci-series system control module.The reagent expired on 30 sep 2025.Quality control and patients were tested on the expired lot of reagents.The customer ran 26 patient samples when the reagent was expired with initial results that ranged from 3.93 mmol/l and 16.60 mmol/l.No repeat results were provided.Upon further review, the customer reported that the selection for override reagent lot expiration was in the "on" position.There was no impact to patient management reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY CI-SERIES SYSTEM CONTROL MODULE
Common Device Name
ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE
Manufacturer (Section D)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer (Section G)
ABBOTT LABORATORIES
1915 hurd drive
irving TX 75038
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key23543951
Report Number3016438761-2025-00674
Device Sequence Number15774038
Product Code JJE
UDI-Device Identifier00380740137410
UDI-Public(01)00380740137410
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K230790
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 11/13/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number03R70-01
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/28/2025
Initial Report FDA Received Date11/13/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/07/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALNT CI SW V3.6.0, 04V20-27, UNKNOWN.
Patient SexUnknown
-
-